Market Tracker

08/18 5:16pm ET

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

31.08
Delayed Data
As of Aug 18
 +0.05 / +0.16%
Today’s Change
20.68
Today|||52-Week Range
40.83
+7.77%
Year-to-Date

Today’s Trading

Previous close31.03
Today’s open31.04
Day’s range30.87 - 31.40
Volume909,596
Average volume (3 months)1,535,890
Market cap$3.8B
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-43.56%
Earnings growth (this year)-9.83%
Earnings growth (next 5 years)+28.93%
Revenue growth (last year)+28,311.48%
P/E ratioNM
Price/Sales192.80
Price/Book7.28

Competitors

 Today’s
change
Today’s
% change
AKRXAkorn Inc-0.62-1.90%
AGNPRAAllergan plc-1.14-0.14%
MNKMallinckrodt Plc+0.03+0.08%
CLVSClovis Oncology Inc+2.09+2.99%
Data as of 4:01pm ET, 08/18/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)-$0.64
Annual revenue (last year)$17.3M
Annual profit (last year)-$271.4M
Net profit margin-1,565.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Vice President-Technology Development &
Operations
James A. Nash
Corporate headquarters
San Diego, California

Forecasts